Annual Report of a Foreign Private Issuer — Form 20-F
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 20-F Annual Report of a Foreign Private Issuer 287 1.54M
2: EX-4.15 Ex-4.15: Framework Transaction Agreement 182 740K
3: EX-4.16 Ex-4.16: Share Sale and Purchase Agreement 20 58K
4: EX-4.17 Ex-4.17: Unofficial Translation of Deed of Trust 47 178K
5: EX-4.18 Ex-4.18: Unofficial Translation of Deed of Trust 47 177K
6: EX-4.20 Ex-4.20: Amended and Restated Loan Agreement 76 248K
7: EX-4.21 Ex-4.21: Lease Agreement 59 146K
8: EX-4.22 Ex-4.22: Hotel Management Agreement 64 136K
9: EX-4.23 Ex-4.23: Amended and Restated Loan Agreement 72 223K
10: EX-4.24 Ex-4.24: Amended and Restated Loan Agreement 71 212K
11: EX-10.1 Ex-10.1: Consent of Brightman Almagor & Co. 1 9K
12: EX-10.2 Ex-10.2: Consent of Plaza Centers (Europe) B.V. 1 9K
13: EX-10.3 Ex-10.3: Consent of Bea Hotels N.V. 1 9K
14: EX-10.4 Ex-10.4: Consent of Gamida Cell Ltd. 1 8K
15: EX-11.1 Ex-11.1: Code of Ethics and Business Conduct 8 38K
16: EX-12.1 Ex-12.1: Certification 2± 11K
17: EX-13.1 Ex-13.1: Certification 1 9K
EX-12.1 — Ex-12.1: Certification
EX-12.1 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
---|
EXHIBIT 12.1
SECTION 302 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL
OFFICER
I, Shimon Yitzhaki, certify that:
1. I have reviewed this annual report on Form 20-F of Elbit Medical Imaging
Ltd. (the "Company");
2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of
the Company as of, and for, the periods presented in this report;
4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
(a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
Company, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in
which this annual report is being prepared;
(b) (Reserved)
(c) evaluated the effectiveness of the Company's disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end
of the period covered by this report based on such evaluation; and
(d) disclosed in this report any change in the Company's internal control
over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably
likely to materially affect, the Company's internal control over
financial reporting; and
5. I have disclosed, based on my most recent evaluation of internal control
over financial reporting, to the Company's auditors and the audit committee
of Company's board of directors (or persons performing the equivalent
functions):
(a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the Company's ability to record,
process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the Company's internal
control over financial reporting.
Date: June 30, 2006
/s/ Shimon Yitzhaki
-------------------------------------
Shimon Yitzhaki
President & Chief Financial Officer
Dates Referenced Herein and Documents Incorporated by Reference
This ‘20-F’ Filing | | Date | | Other Filings |
---|
| | |
Filed on: | | 6/30/06 |
For Period End: | | 12/31/05 | | 6-K |
| List all Filings |
↑Top
Filing Submission 0000950123-06-008462 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Fri., Mar. 29, 3:05:54.1am ET